Jazz Pharmaceuticals
JAZZ
JAZZ
365 hedge funds and large institutions have $7.63B invested in Jazz Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 72 funds opening new positions, 135 increasing their positions, 115 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more capital invested
Capital invested by funds: $7.07B → $7.63B (+$554M)
8% more funds holding
Funds holding: 339 → 365 (+26)
Holders
365
Holding in Top 10
14
Calls
$129M
Puts
$79.4M
Top Buyers
| 1 | +$87.5M | |
| 2 | +$71.3M | |
| 3 | +$60.3M | |
| 4 |
Two Sigma Investments
New York
|
+$56.2M |
| 5 |
Goldman Sachs
New York
|
+$52.5M |
Top Sellers
| 1 | -$322M | |
| 2 | -$74.6M | |
| 3 | -$71.1M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$58.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$36M |